Latham & Watkins advised ShapeTX on the deal. Otsuka Pharmaceutical Co., Ltd. and ShapeTX announced a multi-target collaboration to develop intravitreally-delivered adeno-associated viruses (AAVs) for ocular...
Otsuka’s Collaboration with ShapeTX
Shape Therapeutics’ Gene Therapy Collaboration With Roche
Ropes & Gray advised Shape Therapeutics in the deal. Shape Therapeutics entered into a strategic research collaboration and license agreement with Roche worth up to $3...